Stock Events

Stock Events

PeptiDream 

$7.75
9
+$0+0% Monday 20:00

Statistics

Day High
8.3
Day Low
8.3
52W High
13.75
52W Low
7.75
Volume
100
Avg. Volume
88
Mkt Cap
1.01B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 11
$0.93
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.13
-0.06
0
0.07
Expected EPS
-0.02903712
Actual EPS
N/A

Financials

32.31%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
615.34MRevenue
198.79MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PPTDF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing in the novel drug discovery space similar to PeptiDream's peptide-based discoveries.
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Ionis Pharmaceuticals focuses on RNA-targeted drug discovery, presenting competition in the innovative therapeutic area.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is a leader in gene editing, a cutting-edge area of biotech where PeptiDream could see indirect competition in drug development.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical focuses on rare disease treatments, overlapping with PeptiDream's interest in novel, hard-to-treat conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, areas where PeptiDream's technology could also make an impact.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is a biotech company that develops monoclonal antibodies, a direct competitor in the field of biologic drug development.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biopharmaceutical giant with a broad portfolio, including innovative therapeutics that could compete with PeptiDream's developments.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a global healthcare company with a strong focus on diabetes and obesity, areas where PeptiDream's peptide technology could offer novel treatments.

About

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
Show more...
CEO
Dr. Patrick Crawford Reid Ph.D.
Employees
621
Country
JP
ISIN
JP3836750004

Listings

MX
MX
4587N.MX
OTC Link
US
PPTDF
TSE
JP
4587.TSE

0 Comments

Share your thoughts

FAQ

What is PeptiDream stock price today?▼
The current price of PPTDF is $7.75 USD — it has increased by +0% in the past 24 hours. Watch PeptiDream stock price performance more closely on the chart.
What is PeptiDream stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PeptiDream stocks are traded under the ticker PPTDF.
What is PeptiDream market cap?▼
Today PeptiDream has the market capitalization of 1.01B
When is the next PeptiDream earnings date?▼
PeptiDream is going to release the next earnings report on May 07, 2026.
What were PeptiDream earnings last quarter?▼
PPTDF earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.04 USD resulting in a +27.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PeptiDream revenue for the last year?▼
PeptiDream revenue for the last year amounts to 615.34M USD.
What is PeptiDream net income for the last year?▼
PPTDF net income for the last year is 198.79M USD.
Does PeptiDream pay dividends?▼
Yes, PPTDF dividends are paid annual. The last dividend per share was 0.93 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PeptiDream have?▼
As of April 01, 2026, the company has 621 employees.
In which sector is PeptiDream located?▼
PeptiDream operates in the Health Care sector.
When did PeptiDream complete a stock split?▼
The last stock split for PeptiDream was on June 28, 2017 with a ratio of 2:1.
Where is PeptiDream headquartered?▼
PeptiDream is headquartered in Kawasaki, JP.